Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1834 studies found for:    Hyperinsulinism
Show Display Options
RSS Create an RSS feed from your search for:
Hyperinsulinism
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Conditions: Congenital Hyperinsulinism;   Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   CHI;   PHHI
Interventions: Drug: F-DOPA;   Radiation: PET scan
2 Completed Sandostatine® LP and Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Sandostatine LP
3 Recruiting Fluorodopa F 18 in Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Fluorodopa F 18
4 Recruiting A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Cohort 1;   Drug: Cohort 2;   Drug: Cohort 3;   Drug: Cohort 4
5 Completed Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: exendin-(9-39)
6 Unknown  Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
7 Recruiting Sirolimus for the Treatment of Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: Sirolimus
8 Completed Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
Condition: Non-focal Congenital Hyperinsulinism
Intervention: Procedure: restrictive pancreatic resection
9 Recruiting Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Drug: placebo
10 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39);   Other: placebo
11 Completed Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: recombinant human insulin-like growth factor I
12 Completed Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: insulin-like growth factor I
13 Completed Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: insulin-like growth factor I
14 Completed Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome;   Hyperinsulinism
Interventions: Drug: clomiphene citrate;   Drug: metformin
15 Completed Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
Conditions: Hyperinsulinism;   Polycystic Ovary Syndrome
Interventions: Drug: clomiphene citrate;   Drug: metformin
16 Completed Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
Conditions: Hyperinsulinism;   Hypoglycemia;   Insulinoma
Intervention: Other: 111In-exendin-4 imaging
17 Active, not recruiting Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism (CHI);   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
18 Available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism;   Beckwith-Wiedemann Syndrome;   Insulinoma
Intervention: Drug: 18F-DOPA
19 Available Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Conditions: Hyperinsulinemic Hypoglycemia, Persistent;   Congenital Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
20 Completed Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes
Conditions: Glucose Intolerance;   Hyperinsulinemia;   Diabetes Mellitus, Non Insulin Dependent;   Obesity
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years